Used-car retailer CarMax logged higher profit and sales in its latest quarter as tariff uncertainty sparked an uptick in demand for used cars. It is the first time Rheinmetall will join the ...

Federal Reserve governor Christopher Waller said the central bank could be positioned to cut interest rates at its next meeting in July, notwithstanding potential inflation pressures caused by new ...

The irony, of course, is that Carnival - which ranks as the one of world's most popular cruise lines - is known not just for its signature fun vibe, but also the fact that it's relatively affordable ...

Federal Reserve governor Christopher Waller said the central bank could be positioned to cut interest rates at its next meeting in July, notwithstanding potential inflation pressures caused by new ...

The Public Finance Authority plans to sell $58.2 million of taxable bonds, with Applegreen planning to use proceeds for a service area project on Colorado's E-470 highway.

The S&P/TSX Composite Index is down 6.78 points or 0.03% this week to 26497.57 --Largest one-week point and percentage decline since the week ending May 23, 2025 --Today it is down 8.43 points or 0.03 ...

Walmart will pay $10 million to settle federal charges alleging the retailer allowed scammers to use its in-store money transfer services to steal hundreds of millions of dollars from U.S. consumers.

CarMax has increased revenue and profitability at a remarkable rate, and we think it is positioned to gain market share in any environment. Omnichannel helps this story, as it lets consumer have ...

Consumer companies were flat amid signs that spending was shifting to discounted items and staples from discretionary items. Kroger shares surged after the supermarket chain forecast sales growth, ...

Companies including uranium producer Cameco, investment firm Brookfield Asset Management, GE Vernova, and BWX Technologies are among those that could benefit from exports of U.S. nuclear technology ...

Communications-services companies fell as traders retreated from risk due to concerns about the Israel-Iran conflict and tariff negotiations.

The biopharmaceutical company said Friday that the U.S. Food and Drug Administration has extended the review period by three months to Sept. 19, giving it more time to review additional chemistry, ...